WE-ARE-A-GLOBAL-MRN

We are a Global
Paediatric Research Network

devoted to determining and implementing the best ways
to prevent, diagnose and treat diseases in children

LINKING-EXPERTS-FROM-AROUND-THE-WORLD

Linking experts from
around the world

in an independent global collaboration that seeks to standardize
best practices across disease areas and populations

SHARING-VALUES-AND-GOALS

Sharing Values and Goals

such as flexibility, commitment and transparency

RESEARCHING-THE-RIGHT-DRUG-AND-THE-RIGHT-DOSE

Researching the right drug
and the right dose

to generate the scientific data necessary to market drugs
at doses that are safe and effective for children

UNDERSTNDING-THE-IMMUNE-RESPONSE

Understanding the
Immune Response

so as to harness the body's response
to HIV and antiretrovirals

FIGHTING-ANTIMICROBIAL-RESISTANCE

Fighting
Antimicrobial Resistance

to ensure effective treatments are available
for common infections for generations to come

PAVING-THE-WAY-FOR-WOMEN

Paving the way for women,
children and their families

to make powerful informed decisions about their health
and healthcare and improve the quality of their lives

LATEST NEWS

GET TO KNOW US

Through independent research into child health, Penta is one of the most prominent scientific organizations dedicated to children’s health.

We are an alliance of people united by a common purpose: to improve prevention, diagnosis and treatment of infection in children.

Our global independent scientific network brings together key stakeholders in paediatric infectious disease, including researchers, clinicians, regulatory bodies, the pharmaceutical industry and patients and their families, to develop and deliver world class research and training to drive contemporary understanding and practice related to infections in children.

We are involved in research projects globally that operate along the scientific priorities: HIV & viral infection, severe sepsis and antimicrobial resistance, infection in pregnancy and neglected or emerging childhood infections. We do not just carry out clinical trials, but cohort studies collaboration and pregnancy studies.

Our research embraces basic, pharmacological, clinical, social and population sciences.

Our operational model is based on networking, independence, transparency and commitment.

We continue to build on our existing partnerships and seek out potential new collaborations to further our work.

Keep up to date with the latest Penta news

CURRENT PENTA STUDIES AROUND THE WORLD

ALWAYS EXPANDING

The Penta ID Network continues to grow, bringing together patients and their care-givers worldwide to address a wide range of healthcare issues.

110

CLINICAL SITES

31

COUNTRIES

29

YEARS OF ACTIVITY

24

EU FUNDED PROJECTS

PARTNERSHIPS

Founded in 1950, Doctors with Africa CUAMM is now Italy's leading non-governmental organisation working to protect and improve the wellbeing and health of vulnerable communities in Sub-Saharan Africa.
The Global Antibiotic Research & Development Partnership (GARDP) is a not-for-profit R&D organization that addresses global public health needs by developing and delivering new or improved antibiotic treatments, while endeavouring to ensure their sustainable access.
The INSERM-SC10 clinical trials unit was created to enhance the cooperative effort between clinicians and biologists involved in HIV therapeutic trials and to develop this endeavour on a European scale.
The MRC Clinical Trials Unit at UCL is at the forefront of resolving internationally important questions in infections and cancer, and delivering swifter and more effective translation of scientific research into patient benefits.
PHPT is an international collaborative research programme between the Faculty of Associated Medical Sciences at Chiang Mai University in Thailand, and the Institut de recherche pour le développement (IRD) in France. Its overall goal is to help improve HIV prevention and care at the family level through clinical research.
NEWSLETTER

We would like to update you on our recent activities